Last updated: 8 days ago
Gilead Sciences Q2 2025 Financial Report: Strong Growth Amid Legal Challenges
Explore Gilead Sciences' Q2 2025 financial report showcasing revenue growth in HIV therapy. Key insights on profitability, expenses, and market outlook for informed investment decisions.